A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males

A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)

NCT00293267 ·Status: COMPLETED ·Phase: PHASE3

A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients

NCT00002190 ·Status: COMPLETED ·Phase: PHASE2

A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients

NCT00002195 ·Status: COMPLETED ·Phase: PHASE3

Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects

NCT00000882 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

NCT00002420 ·Status: TERMINATED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

NCT02607930 ·Status: COMPLETED ·Phase: PHASE3

A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients

NCT00001094 ·Status: WITHDRAWN ·Phase: PHASE2

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

NCT00046176 ·Status: COMPLETED ·Phase: PHASE3

A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients

NCT00002400 ·Status: COMPLETED ·Phase: NA

A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects

NCT00363142 ·Status: COMPLETED ·Phase: PHASE3

A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

NCT00002440 ·Status: COMPLETED ·Phase: PHASE2

Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.

NCT00158821 ·Status: COMPLETED ·Phase: PHASE3

Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients

NCT00823966 ·Status: COMPLETED

Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients

NCT00084253 ·Status: COMPLETED ·Phase: PHASE4

A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071)

NCT00745823 ·Status: TERMINATED ·Phase: PHASE3

Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients

NCT00004999 ·Status: SUSPENDED ·Phase: PHASE2

A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

NCT00002382 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare Two Anti-HIV Drug Combinations

NCT00002447 ·Status: COMPLETED ·Phase: PHASE3

Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive

NCT01489046 ·Status: TERMINATED ·Phase: PHASE2

Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs

NCT00004852 ·Status: COMPLETED ·Phase: PHASE2

TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.

NCT00245739 ·Status: APPROVED_FOR_MARKETING

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

NCT00043888 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults

NCT02603107 ·Status: COMPLETED ·Phase: PHASE3

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

NCT00000940 ·Status: COMPLETED ·Phase: PHASE2

A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients

NCT00002448 ·Status: COMPLETED ·Phase: PHASE3